Retour
Fourchette du Jour
4,82 €
4,95 €
Fourchette 52 Semaines
3,02 €
22,42 €
Volume
26 545
Moyenne 50J / 200J
4,71 €
/
6,01 €
Clôture Précédente
4,83 €
Quick Summary
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -77,9 | 0,3 |
| P/B | 24,7 | 3,0 |
| ROE % | -46,9 | 3,7 |
| Net Margin % | -28,6 | 3,8 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,1 | 0,2 |
Objectif de Cours des Analystes
Aucune couverture d'analyste disponible
Estimations de Bénéfices
Aucune estimation prévisionnelle disponible
No quarterly estimates available
Dividend History
Yield
0,00%
Payout Ratio
0,00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Points Clés
Debt/Equity of 0,08 — conservative balance sheet
Negative free cash flow of -22,20M
Capital efficient — spends only 8,63% of revenue on capex
Croissance
Revenue Growth (5Y)
N/A
Revenue (1Y)105,40%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-46,94%
ROIC-14,86%
Net Margin-28,59%
Op. Margin-19,22%
Sécurité
Debt / Equity
0,08
Current Ratio1,86
Interest Coverage-7,35
Valorisation
P/E Ratio
-77,89
Forward P/EN/A
P/B Ratio24,72
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 105,40% | Revenue Growth (3Y) | 168,58% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 42,41M | Net Income (TTM) | -12,13M |
| ROE | -46,94% | ROA | -16,34% |
| Gross Margin | 43,38% | Operating Margin | -19,22% |
| Net Margin | -28,59% | Free Cash Flow (TTM) | -22,20M |
| ROIC | -14,86% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,08 | Current Ratio | 1,86 |
| Interest Coverage | -7,35 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | 0,00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -77,89 | Forward P/E | N/A |
| P/B Ratio | 24,72 | P/S Ratio | 22,27 |
| PEG Ratio | 2,12 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -2,35% | ||
| Market Cap | 944,58M | Enterprise Value | 944,29M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 42,41M | 20,65M | 5,88M | 1,46M | 0,0 |
| Net Income | -12,13M | -19,15M | -20,94M | -5,60M | -1,48M |
| EPS (Diluted) | -0,06 | -0,10 | -0,16 | -1,41 | -0,52 |
| Gross Profit | 18,40M | 8,45M | 713 447,0 | 489 594,0 | -18 787,0 |
| Operating Income | -8,15M | -18,98M | -20,67M | -5,68M | -1,41M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 74,23M | 42,39M | 25,48M | 6,98M | 428 607,0 |
| Total Liabilities | 36,01M | 28,93M | 11,18M | 9,66M | 287 281,0 |
| Shareholders' Equity | 38,22M | 13,46M | 14,30M | -2,68M | 141 326,0 |
| Total Debt | 2,92M | 18,20M | 8,22M | 8,27M | 145 000,0 |
| Cash & Equivalents | 3,21M | 466 500,0 | 7,03M | 217 177,0 | 405 774,0 |
| Current Assets | 48,80M | 27,42M | 18,38M | 4,10M | 408 065,0 |
| Current Liabilities | 26,24M | 21,33M | 9,27M | 7,77M | 287 281,0 |